Company / Cost of Revenue
Chemed Corp. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.7B
FY2025
5-year range
$1.4B / $1.7B
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#32 of 107
Health Care
What the data says
At $1.7B, Chemed Corp.'s cost of revenue ranks #76 of 107 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $1.4B in FY2021 to $1.7B in FY2025.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +4.4%.
Increased from $1.5B to $1.7B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +4.4%
- 10-Year CAGR
- -
Sector benchmark
#76 of 107 in Health CareTop 70% of 107This company $1.7B Sector average $11.8B
▼
-85.5% below sector average
Key checks
Key Insights
- Chemed Corp.'s cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +4.4%, indicating consistent growth.
- In FY2025, cost of revenue increased 8.2% year-over-year.
- Ranks #32 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | +8.2% |
| FY2024 | $1.6B | +7.6% |
| FY2023 | $1.5B | +7.0% |
| FY2022 | $1.4B | +0.0% |
| FY2021 | $1.4B | -0.6% |
| FY2020 | $1.4B | +4.3% |
| FY2019 | $1.3B | +7.6% |
| FY2018 | $1.2B | +6.7% |
| FY2017 | $1.2B | +3.1% |
| FY2016 | $1.1B | +2.6% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026